MetLife [MET] vs Globe Life [GL] Detailed Stock Comparison
MetLife
NYSE
Loading...
Globe Life
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: MetLife wins in 9 metrics, Globe Life wins in 10 metrics, with 0 ties. Globe Life appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | MetLife | Globe Life | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.85 | 11.30 | Globe Life |
| Price-to-Book Ratio | 1.84 | 2.15 | MetLife |
| Debt-to-Equity Ratio | 134.25 | 58.41 | Globe Life |
| PEG Ratio | 7.88 | 10.37 | MetLife |
| EV/EBITDA | 8.20 | 9.55 | MetLife |
| Profit Margin (TTM) | 5.87% | 18.11% | Globe Life |
| Operating Margin (TTM) | 5.64% | 23.51% | Globe Life |
| EBITDA Margin (TTM) | 5.64% | 23.51% | Globe Life |
| Return on Equity | 15.51% | 20.18% | Globe Life |
| Return on Assets (TTM) | 0.59% | 3.68% | Globe Life |
| Free Cash Flow (TTM) | $14.60B | $1.33B | MetLife |
| Dividend Yield | 2.10% | 0.82% | MetLife |
| 1-Year Return | 8.76% | 52.74% | Globe Life |
| Price-to-Sales Ratio (TTM) | 0.70 | 1.98 | MetLife |
| Enterprise Value | $59.48B | $14.40B | MetLife |
| EV/Revenue Ratio | 0.82 | 2.45 | MetLife |
| Revenue per Share (TTM) | $106 | $70 | MetLife |
| Earnings per Share (Diluted) | $5.94 | $12.43 | Globe Life |
| Beta (Stock Volatility) | 0.83 | 0.56 | Globe Life |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
MetLife vs Globe Life Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| MetLife | 3.32% | 3.05% | -4.26% | -1.70% | -8.20% | -6.74% |
| Globe Life | 0.04% | 2.41% | 16.07% | 15.94% | 14.97% | 25.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| MetLife | 8.76% | 12.48% | 92.55% | 56.26% | 116.31% | 75.49% |
| Globe Life | 52.74% | 36.11% | 64.42% | 124.88% | 524.67% | 518.62% |
Performance & Financial Health Analysis: MetLife vs Globe Life
| Metric | MET | GL |
|---|---|---|
| Market Information | ||
| Market Cap | $50.91B | $11.66B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 3,925,344 | 887,150 |
| 90 Day Avg. Volume | 3,023,445 | 744,647 |
| Last Close | $76.27 | $140.55 |
| 52 Week Range | $65.21 - $89.05 | $89.13 - $144.00 |
| % from 52W High | -14.35% | -2.40% |
| All-Time High | $89.05 (Nov 25, 2024) | $142.21 (Aug 07, 2025) |
| % from All-Time High | -14.35% | -1.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.03% |
| Quarterly Earnings Growth | -0.23% | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.18% |
| Operating Margin (TTM) | 0.06% | 0.24% |
| Return on Equity (TTM) | 0.16% | 0.20% |
| Debt to Equity (MRQ) | 134.25 | 58.41 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.52 | $65.43 |
| Cash per Share (MRQ) | $41.21 | $4.44 |
| Operating Cash Flow (TTM) | $-1,083,000,000 | $1.05B |
| Levered Free Cash Flow (TTM) | $4.23B | $1.07B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.10% | 0.82% |
| Last 12-Month Dividend | $1.65 | $0.99 |
Valuation & Enterprise Metrics Analysis: MetLife vs Globe Life
| Metric | MET | GL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.85 | 11.30 |
| Forward P/E | 7.88 | 10.37 |
| PEG Ratio | 7.88 | 10.37 |
| Price to Sales (TTM) | 0.70 | 1.98 |
| Price to Book (MRQ) | 1.84 | 2.15 |
| Market Capitalization | ||
| Market Capitalization | $50.91B | $11.66B |
| Enterprise Value | $59.48B | $14.40B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.82 | 2.45 |
| Enterprise to EBITDA | 8.20 | 9.55 |
| Risk & Other Metrics | ||
| Beta | 0.83 | 0.56 |
| Book Value per Share (MRQ) | $41.52 | $65.43 |
Financial Statements Comparison: MetLife vs Globe Life
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MET | GL |
|---|---|---|
| Revenue/Sales | $18.28B | $1.48B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $1.35B | $316.08M |
| Income Tax | $404.00M | $61.52M |
| Net Income (Profit) | $950.00M | $254.56M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MET | GL |
|---|---|---|
| Cash & Equivalents | $21.33B | $232.27M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $18.85B | $2.32B |
| Total Shareholders Equity | $27.76B | $5.43B |
| Retained Earnings | $43.13B | $8.22B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MET | GL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | $-11.75M |
| Free Cash Flow | $4.26B | $420.14M |
| Debt Repayment | $-810.00M | $-192.98M |
| Common Stock Repurchase | $-1.41B | $-264.54M |
Short Interest & Institutional Ownership Analysis
| Metric | MET | GL |
|---|---|---|
| Shares Short | 8.07M | 1.32M |
| Short Ratio | 2.76 | 2.10 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 3,925,344 | 887,150 |
| Average Daily Volume (90 Day) | 3,023,445 | 744,647 |
| Shares Outstanding | 689.21M | 83.98M |
| Float Shares | 556.04M | 81.83M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.92% | 0.86% |
Dividend Analysis & Yield Comparison: MetLife vs Globe Life
| Metric | MET | GL |
|---|---|---|
| Last 12-Month Dividend | $1.65 | $0.99 |
| Last 12-Month Dividend Yield | 2.10% | 0.82% |
| 3-Year Avg Annual Dividend | $1.93 | $0.85 |
| 3-Year Avg Dividend Yield | 0.77% | 0.21% |
| 3-Year Total Dividends | $5.78 | $2.55 |
| Ex-Dividend Date | Feb 04, 2025 | Apr 03, 2025 |